DaTscan Imaging
BJ Grabher - Journal of Nuclear Medicine Technology, 2019 - Soc Nuclear Med
DaTscan (123I-ioflupane injection; GE Healthcare) is a molecular imaging agent that shows
the location and concentration of dopamine transporters (DaTs) in the synapses of striatal …
the location and concentration of dopamine transporters (DaTs) in the synapses of striatal …
Clinical usefulness of dopamine transporter imaging
JM Kim, YK Kim, SE Kim… - Nuclear Medicine and …, 2007 - pesquisa.bvsalud.org
Imaging of the dopamine transporter (DAT) provides a marker for the integrity of presynaptic
nigrostriatal dopaminergic system. DAT density is reduced in Parkinson disease, multiple …
nigrostriatal dopaminergic system. DAT density is reduced in Parkinson disease, multiple …
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0
DSW Djang, MJR Janssen, N Bohnen… - Journal of Nuclear …, 2012 - Soc Nuclear Med
Nv-fluoropropyl-2b-carbomethoxy-3b-(4-123I-iodophenyl) nortropane (123I-ioflupane) is a
molecular imaging agent used to demonstrate the location and concentration of dopamine …
molecular imaging agent used to demonstrate the location and concentration of dopamine …
Molecular imaging of the dopamine transporter
A Varrone, C Halldin - Journal of Nuclear Medicine, 2010 - Soc Nuclear Med
The dopamine transporter (DAT) is a transmembrane protein responsible for reuptake of
dopamine from the synaptic cleft and termination of dopaminergic transmission. Several …
dopamine from the synaptic cleft and termination of dopaminergic transmission. Several …
I-123 Ioflupane dopamine transporter imaging: Interesting case studies including technical and quality assurance pitfalls
M Ksepka, M Becker, A Naidu, L Sokol, S Basak… - 2014 - Soc Nuclear Med
1266 Learning Objectives 1. Review the use of DaT imaging of the nigrostriatal
dopaminergic system in patients with clinically uncertain Parkinsonian syndromes. 2 …
dopaminergic system in patients with clinically uncertain Parkinsonian syndromes. 2 …
Human brain imaging of dopamine transporters
A Varrone, C Halldin - Imaging of the human brain in health and disease, 2014 - Elsevier
The dopamine transporter (DAT) is a transmembrane protein that is responsible for the
reuptake of dopamine (DA) from the synaptic cleft and for the termination of dopaminergic …
reuptake of dopamine (DA) from the synaptic cleft and for the termination of dopaminergic …
Nuclear neuroimaging of dopamine transporter in Parkinsonism--role in routine clinical practice
M Cohenpour, H Golan - Harefuah, 2007 - europepmc.org
Idiopathic Parkinson's disease (IPD) is a neurodegenerative condition characterized
pathologically by the degeneration of dopaminergic neuron in the substantia nigra and …
pathologically by the degeneration of dopaminergic neuron in the substantia nigra and …
[HTML][HTML] Molecular imaging of the dopamine transporter
G Palermo, R Ceravolo - Cells, 2019 - mdpi.com
Dopamine transporter (DAT) single-photon emission tomography (SPECT) with (123)
Ioflupane is a widely used diagnostic tool for patients with suspected parkinsonian …
Ioflupane is a widely used diagnostic tool for patients with suspected parkinsonian …
Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders
Single photon emission computed tomography (SPECT) tracers selective for pre-and post-
synaptic targets have allowed measurements of several aspects of dopaminergic (DA) …
synaptic targets have allowed measurements of several aspects of dopaminergic (DA) …
Pearls and pitfalls of I-123 Ioflupane (DATscan) SPECT imaging
A Chaudhry, M Gul, D Franceschi, R Matthews - 2013 - Soc Nuclear Med
1284 Learning Objectives 1. Review the anatomy, pathophysiology, and imaging findings
including SPECT imaging (DATscan), CT, and MRI of various movement disorders including …
including SPECT imaging (DATscan), CT, and MRI of various movement disorders including …